156 related articles for article (PubMed ID: 17001519)
21. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
[TBL] [Abstract][Full Text] [Related]
22. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.
Mäkelä KS; Haapasalo JA; Ilvesaro JM; Parkkila S; Paavonen T; Haapasalo HK
Histol Histopathol; 2014 Sep; 29(9):1161-8. PubMed ID: 24599602
[TBL] [Abstract][Full Text] [Related]
23. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
[TBL] [Abstract][Full Text] [Related]
24. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression.
Comincini S; Facoetti A; Del Vecchio I; Peoc'h K; Laplanche JL; Magrassi L; Ceroni M; Ferretti L; Nano R
Anticancer Res; 2004; 24(3a):1507-17. PubMed ID: 15274317
[TBL] [Abstract][Full Text] [Related]
26. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation of multiple genes in astrocytic gliomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
[TBL] [Abstract][Full Text] [Related]
28. Mutations in Rb1 pathway-related genes are associated with poor prognosis in anaplastic astrocytomas.
Bäcklund LM; Nilsson BR; Liu L; Ichimura K; Collins VP
Br J Cancer; 2005 Jul; 93(1):124-30. PubMed ID: 15970925
[TBL] [Abstract][Full Text] [Related]
29. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival.
Kunwar S; Mohapatra G; Bollen A; Lamborn KR; Prados M; Feuerstein BG
Cancer Res; 2001 Oct; 61(20):7683-8. PubMed ID: 11606412
[TBL] [Abstract][Full Text] [Related]
30. O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course.
Watanabe T; Katayama Y; Komine C; Yoshino A; Ogino A; Ohta T; Fukushima T
Int J Cancer; 2005 Feb; 113(4):581-7. PubMed ID: 15455376
[TBL] [Abstract][Full Text] [Related]
31. Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type.
Salmon I; Dewitte O; Pasteels JL; Flament-Durand J; Brotchi J; Vereerstraeten P; Kiss R
J Neurosurg; 1994 May; 80(5):877-83. PubMed ID: 8169628
[TBL] [Abstract][Full Text] [Related]
32. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
[TBL] [Abstract][Full Text] [Related]
34. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors.
Bian XW; Shi JQ; Liu FX
Anal Quant Cytol Histol; 2000 Dec; 22(6):429-37. PubMed ID: 11147296
[TBL] [Abstract][Full Text] [Related]
35. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
[TBL] [Abstract][Full Text] [Related]
36. Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases.
Rickert CH; Sträter R; Kaatsch P; Wassmann H; Jürgens H; Dockhorn-Dworniczak B; Paulus W
Am J Pathol; 2001 Apr; 158(4):1525-32. PubMed ID: 11290570
[TBL] [Abstract][Full Text] [Related]
37. Gene expression microarray analysis reveals prognostic markers of survival in high grade astrocytomas.
Yang J; Hou Z; Wang C; Wang H; Zhang H
Neurol Res; 2018 Sep; 40(9):744-751. PubMed ID: 29781781
[TBL] [Abstract][Full Text] [Related]
38. Post-contrast enhancement as a clinical indicator of prognosis in patients with anaplastic astrocytoma.
Matar E; Cook RJ; Fowler AR; Biggs MT; Little NS; Wheeler HR; Robinson BG; McDonald KL
J Clin Neurosci; 2010 Aug; 17(8):993-6. PubMed ID: 20605464
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
40. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours.
Miyakawa A; Ichimura K; Schmidt EE; Varmeh-Ziaie S; Collins VP
Br J Cancer; 2000 Feb; 82(3):543-9. PubMed ID: 10682663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
